The role of CD4 T cells in the pathogenesis of multiple sclerosis

被引:120
作者
Chitnis, Tanuja [1 ]
机构
[1] Harvard Univ, Sch Med, Brigham & Womens Hosp, Dept Neurol, Boston, MA 02115 USA
来源
NEUROBIOLOGY OF MULTIPLE SCLEROSIS | 2007年 / 79卷
关键词
MYELIN-BASIC-PROTEIN; EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; CENTRAL-NERVOUS-SYSTEM; TUMOR-NECROSIS-FACTOR; PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY; CD40-CD40 LIGAND INTERACTIONS; PERIPHERAL-BLOOD LYMPHOCYTES; PLACEBO-CONTROLLED TRIAL; ALTERED PEPTIDE LIGAND; PHASE-III MULTICENTER;
D O I
10.1016/S0074-7742(07)79003-7
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
T lymphocytes play a central role in the pathogenesis of multiple sclerosis (MS) (Zhang et al., 1992). Both CD4+ and CD8+ T cells have been demonstrated in MS lesions, with CD4+ T cells predominating in acute lesions and CD8+ T cells being observed more frequently in chronic lesions (Raine, 1994). Additionally, T cells are found in all four of the described histopathologic subtypes of MS (Lucchinetti et al., 2000). Activated myelin-reactive CD4+ T cells are present in the blood and cerebrospinal fluid (CSF of MS patients; in contrast, only nonactivated myelinreactive T cells are present in the blood of controls (Zhang et al., 1994). The success of several T-cell-targeted therapies in MS reinforces the importance of the role of the T cell in MS pathogenesis. Here, we outline basic concepts in CD4+ T-cell immunology and summarize the current understanding of the role of CD4+ T cells in the pathogenesis of MS.
引用
收藏
页码:43 / 72
页数:30
相关论文
共 185 条
[1]   T cell vaccination in multiple sclerosis relapsing-remitting nonresponders patients [J].
Achiron, A ;
Lavie, G ;
Kishner, I ;
Stern, Y ;
Sarova-Pinhas, I ;
Ben-Aharon, T ;
Barak, Y ;
Raz, H ;
Lavie, M ;
Barliya, T ;
Faibel, M ;
Cohen, IR ;
Mandel, M .
CLINICAL IMMUNOLOGY, 2004, 113 (02) :155-160
[2]   Interleukin-23 promotes a distinct CD4 T cell activation state characterized by the production of interleukin-17 [J].
Aggarwal, S ;
Ghilardi, N ;
Xie, MH ;
de Sauvage, FJ ;
Gurney, AL .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2003, 278 (03) :1910-1914
[3]   Copolymer 1 acts against the immunodominant epitope 82-100 of myelin basic protein by T cell receptor antagonism in addition to major histocompatibility complex blocking [J].
Aharoni, R ;
Teitelbaum, D ;
Arnon, R ;
Sela, M .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1999, 96 (02) :634-639
[4]   Glatiramer acetate-specific T cells in the brain express T helper 2/3 cytokines and brain-derived neurotrophic factor in situ [J].
Aharoni, R ;
Kayhan, B ;
Eilam, R ;
Sela, M ;
Arnon, R .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2003, 100 (24) :14157-14162
[5]   Specific Th2 cells accumulate in the central nervous system of mice protected against experimental autoimmune encephalomyelitis by copolymer 1 [J].
Aharoni, R ;
Teitelbaum, D ;
Leitner, O ;
Meshorer, A ;
Sela, M ;
Arnon, R .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2000, 97 (21) :11472-11477
[6]   Oral treatment of mice with copolymer 1 (glatiramer acetate) results in the accumulation of specific Th2 cells in the central nervous system [J].
Aharoni, R ;
Meshorer, A ;
Sela, M ;
Arnon, R .
JOURNAL OF NEUROIMMUNOLOGY, 2002, 126 (1-2) :58-68
[7]   T-cell regulation by CD28 and CTLA-4 [J].
Alegre, ML ;
Frauwirth, KA ;
Thompson, CB .
NATURE REVIEWS IMMUNOLOGY, 2001, 1 (03) :220-228
[8]   T-CELLS RESPONSIVE TO MYELIN BASIC-PROTEIN IN PATIENTS WITH MULTIPLE-SCLEROSIS [J].
ALLEGRETTA, M ;
NICKLAS, JA ;
SRIRAM, S ;
ALBERTINI, RJ .
SCIENCE, 1990, 247 (4943) :718-721
[9]   HIGH-LEVELS OF INTERLEUKIN-10 PRODUCTION IN-VIVO ARE ASSOCIATED WITH TOLERANCE IN SCID PATIENTS TRANSPLANTED WITH HLA MISMATCHED HEMATOPOIETIC STEM-CELLS [J].
BACCHETTA, R ;
BIGLER, M ;
TOURAINE, JL ;
PARKMAN, R ;
TOVO, PA ;
ABRAMS, J ;
MALEFYT, RD ;
DEVRIES, JE ;
RONCAROLO, MG .
JOURNAL OF EXPERIMENTAL MEDICINE, 1994, 179 (02) :493-502
[10]   CD4+CD25high regulatory cells in human peripheral blood [J].
Baecher-Allan, C ;
Brown, JA ;
Freeman, GJ ;
Hafler, DA .
JOURNAL OF IMMUNOLOGY, 2001, 167 (03) :1245-1253